MALAT1 and epilepsy: Recent studies indicate that abnormal HCN channel expression, pathogenic genetic variants, or dysregulated protein interactions are closely linked to the onset and progression of epilepsy and may contribute to disease by destabilizing membrane-potential homeostasis, perturbing neurotransmitter balance, and disrupting network-level control of excitability.